CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis

類似資料

• Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
  著者:: Öhman, Lena, 等
  出版事項: (2021)
• Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis
  著者:: Jonefjäll, Börje, 等
  出版事項: (2017)
• Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study
  著者:: Lasson, Anders, 等
  出版事項: (2015)
• Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease
  著者:: Mavroudis, Georgios, 等
  出版事項: (2019)
• Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease
  著者:: Strömbeck, Anna, 等
  出版事項: (2020)